These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23694700)

  • 1. Adjusting for background mutation frequency biases improves the identification of cancer driver genes.
    Evans P; Avey S; Kong Y; Krauthammer M
    IEEE Trans Nanobioscience; 2013 Sep; 12(3):150-7. PubMed ID: 23694700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic synonymous mutations in regulatory elements contribute to the genetic aetiology of melanoma.
    Zhang D; Xia J
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):43. PubMed ID: 32241263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
    Hua X; Xu H; Yang Y; Zhu J; Liu P; Lu Y
    Am J Hum Genet; 2013 Sep; 93(3):439-51. PubMed ID: 23954162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional relevance of somatic synonymous mutations in melanoma and other cancers.
    Gotea V; Gartner JJ; Qutob N; Elnitski L; Samuels Y
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):673-84. PubMed ID: 26300548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsynonymous, synonymous and nonsense mutations in human cancer-related genes undergo stronger purifying selections than expectation.
    Chu D; Wei L
    BMC Cancer; 2019 Apr; 19(1):359. PubMed ID: 30991970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of mutational signatures of synonymous mutations across 15 cancer types.
    Bin Y; Wang X; Zhao L; Wen P; Xia J
    BMC Med Genet; 2019 Dec; 20(Suppl 2):190. PubMed ID: 31815613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating mutational heterogeneity to identify genes that are enriched for synonymous mutations in cancer.
    Rao Y; Ahmed N; Pritchard J; O'Brien EP
    BMC Bioinformatics; 2023 Dec; 24(1):462. PubMed ID: 38062391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular evolution of synonymous codon usage in Populus.
    Ingvarsson PK
    BMC Evol Biol; 2008 Nov; 8():307. PubMed ID: 18983655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domain landscapes of somatic mutations in cancer.
    Nehrt NL; Peterson TA; Park D; Kann MG
    BMC Genomics; 2012 Jun; 13 Suppl 4(Suppl 4):S9. PubMed ID: 22759657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genomic landscape of cutaneous melanoma.
    Zhang T; Dutton-Regester K; Brown KM; Hayward NK
    Pigment Cell Melanoma Res; 2016 May; 29(3):266-83. PubMed ID: 26833684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On measuring selection in cancer from subclonal mutation frequencies.
    Bozic I; Paterson C; Waclaw B
    PLoS Comput Biol; 2019 Sep; 15(9):e1007368. PubMed ID: 31557163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo discovery of mutated driver pathways in cancer.
    Vandin F; Upfal E; Raphael BJ
    Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison and integration of computational methods for deleterious synonymous mutation prediction.
    Cheng N; Li M; Zhao L; Zhang B; Yang Y; Zheng CH; Xia J
    Brief Bioinform; 2020 May; 21(3):970-981. PubMed ID: 31157880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Epistasis in Cancer Genomes: A Delicate Affair.
    van de Haar J; Canisius S; Yu MK; Voest EE; Wessels LFA; Ideker T
    Cell; 2019 May; 177(6):1375-1383. PubMed ID: 31150618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms.
    Zhang J; Zhang S
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):988-998. PubMed ID: 28113329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural selection on synonymous and nonsynonymous mutations shapes patterns of polymorphism in Populus tremula.
    Ingvarsson PK
    Mol Biol Evol; 2010 Mar; 27(3):650-60. PubMed ID: 19837657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying gene selection in cancer through protein functional alteration bias.
    Brandes N; Linial N; Linial M
    Nucleic Acids Res; 2019 Jul; 47(13):6642-6655. PubMed ID: 31334812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Code of Silence: Widespread Associations Between Synonymous Codon Biases and Gene Function.
    Supek F
    J Mol Evol; 2016 Jan; 82(1):65-73. PubMed ID: 26538122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.